Marathon Digital Holdings Inc vs Oruka Therapeutics Inc. Common Stock — how do they compare? Marathon Digital Holdings Inc trades at $8.06 (market cap $3.18B), while Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.08B). The key difference: Oruka Therapeutics Inc. Common Stock is the larger of the two by market cap, and Oruka Therapeutics Inc. Common Stock is trading nearer its 52-week high, Marathon Digital Holdings Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Marathon Digital Holdings Inc for 22 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.
| MARA | ORKA | |
|---|---|---|
Market Cap | $3.18B | $5.08B |
Volume | 38,632,805 | 685,276 |
Sector | Financials | Health |
52-Week High | $22.84 | $113.08 |
52-Week Low | $6.73 | $26.19 |
Typical Hold Time | 22 Days | 0 Days |
Enterprise Value | $5.22B | $4.21B |
Signals from Pluang's Aura AI — not financial advice
Marathon Digital Holdings (MARA) trades at $9.11, down 3.5% on the day, with technical indicators showing bearish momentum despite some oversold RSI signals. The company faces significant fundamental challenges with a net income margin of -429.71% and consecutive earnings misses, though analyst sentiment remains divided with a $13 consensus price target representing 43% upside potential.
While valuation metrics appear attractive with low P/E and EV/EBITDA ratios, persistent losses and negative cash flow from operations pose substantial risks. The stock's performance remains heavily tied to Bitcoin sentiment, creating volatility exposure. Analyst consensus leans neutral with equal buy/hold ratings, suggesting cautious optimism amid operational challenges.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Marathon Digital Holdings, Inc. is one of the largest publicly traded Bitcoin mining companies in North America. The company focuses on building and operating large-scale, cost-efficient Bitcoin mining facilities. Marathon's strategy centers on increasing its mining hash rate and using sustainable energy sources to expand its Bitcoin production. The company's performance is closely tied to the price of Bitcoin and the overall health of the digital asset mining industry.
Read more on MARA →Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →